JZP458
Showing 1 - 4 of 4
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial (Asparaginase Erwinia Chrysanthemi (recombinant))
Approved for marketing
- Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- Asparaginase Erwinia Chrysanthemi (recombinant)
- (no location specified)
Jul 27, 2021
Acute Lymphoblastic Leukemia, Lymphoblastic Leukemia Trial in Canada, United States (IM JZP-458, IV JZP-458)
Completed
- Acute Lymphoblastic Leukemia
- Lymphoblastic Leukemia
- IM JZP-458
- IV JZP-458
-
Birmingham, Alabama
- +73 more
Aug 3, 2022
Narcolepsy, Obstructive Sleep Apnea Trial in Worldwide (JZP-110)
Completed
- Narcolepsy
- Obstructive Sleep Apnea
-
Birmingham, Alabama
- +79 more
Jun 4, 2019
Graft-versus-host Disease, Acute-graft-versus-host Disease Trial in Worldwide (Defibrotide, Standard of Care)
Completed
- Graft-versus-host Disease
- Acute-graft-versus-host Disease
- Defibrotide
- Standard of Care
-
Los Angeles, California
- +61 more
Jul 26, 2021